Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation

Antiarrhythmic Effect of Ranolazine in Combination with Class III Drugs in an Experimental Whole-Heart Model of Atrial Fibrillation

(2013) Gerrit Frommeyer et al.   Cardiovascular Therapeutics

Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey

(2013) A. Hernandez-Madrid et al.   EUROPACE

Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness

(2013) Peter Milberg et al.   EUROPACE

Comparison of Effectiveness of Ranolazine Plus Amiodarone Versus Amiodarone Alone for Conversion of Recent-Onset Atrial Fibrillation

(2012) Nikolaos Fragakis et al.   AMERICAN JOURNAL OF CARDIOLOGY

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey

(2012) R. Pisters et al.   EUROPACE

The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine

(2012) Ewa Karwatowska-Prokopczuk et al.   EUROPACE

Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation

(2012) R. L. Verrier et al.   EUROPACE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Antiarrhythmic properties of ranolazine – from bench to bedside

(2012) Stylianos Tzeis et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The Use of Ranolazine to Facilitate Electrical Cardioversion in Cardioversion-Resistant Patients: A Case Series

(2012) DAVID K. MURDOCK et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Comparison of Effectiveness and Safety of Ranolazine Versus Amiodarone for Preventing Atrial Fibrillation After Coronary Artery Bypass Grafting

(2011) Ronald H. Miles et al.   AMERICAN JOURNAL OF CARDIOLOGY

Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias

(2010) Donglin Guo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Altered Na+Currents in Atrial Fibrillation

(2010) Samuel Sossalla et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Synergistic Effect of the Combination of Ranolazine and Dronedarone to Suppress Atrial Fibrillation

(2010) Alexander Burashnikov et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Late Na+Current Inhibition by Ranolazine Reduces Torsades de Pointes in the Chronic Atrioventricular Block Dog Model

(2010) Gudrun Antoons et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Synergistic Electrophysiologic and Antiarrhythmic Effects of the Combination of Ranolazine and Chronic Amiodarone in Canine Atria

(2009) Serge Sicouri et al.   Circulation-Arrhythmia and Electrophysiology

Ranolazine Exerts Potent Effects on Atrial Electrical Properties and Abbreviates Atrial Fibrillation Duration in the Intact Porcine Heart

(2009) KAPIL KUMAR et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation

(2009) Charles Antzelevitch et al.   JOURNAL OF ELECTROCARDIOLOGY

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches

(2008) I. Savelieva et al.   EUROPACE

Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations

(2008) Serge Sicouri et al.   HEART RHYTHM